|
|
| 5HT4R_CAVPO |
HTR4 |
5-hydroxytryptamine receptor 4 |
4.068e-101 |
1.00
|
| 5HT3B_RAT |
Htr3b |
5-hydroxytryptamine receptor 3B |
3.955e-33 |
1.00
|
| 5HT3A_RAT |
Htr3a |
5-hydroxytryptamine receptor 3A |
1.492e-26 |
1.00
|
| KCNH2_HUMAN |
KCNH2 |
Potassium voltage-gated channel subfamily H member 2 |
2.613e-17 |
1.00
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
3.525e-06 |
1.00
|
| ADA2A_HUMAN |
ADRA2A |
Alpha-2A adrenergic receptor |
7.132e-05 |
1.00
|
| ADA2B_HUMAN |
ADRA2B |
Alpha-2B adrenergic receptor |
8.435e-05 |
1.00
|
| 5HT2B_HUMAN |
HTR2B |
5-hydroxytryptamine receptor 2B |
0.0008962 |
1.00
|
| 5HT2C_HUMAN |
HTR2C |
5-hydroxytryptamine receptor 2C |
0.002388 |
1.00
|
| CP2C9_HUMAN |
CYP2C9 |
Cytochrome P450 2C9 |
0.01244 |
1.00
|
| CP3A4_HUMAN |
CYP3A4 |
Cytochrome P450 3A4 |
0.02268 |
1.00
|
| CP2CJ_HUMAN |
CYP2C19 |
Cytochrome P450 2C19 |
0.03377 |
1.00
|
| CP1A2_HUMAN |
CYP1A2 |
Cytochrome P450 1A2 |
0.151 |
1.00
|
| SC6A4_HUMAN |
SLC6A4 |
Sodium-dependent serotonin transporter |
0.9209 |
1.00
|
| 5HT4R_HUMAN |
HTR4 |
5-hydroxytryptamine receptor 4 |
4.691e-128 |
0.63
|
| 5HT4R_RAT |
Htr4 |
5-hydroxytryptamine receptor 4 |
1.969e-124 |
0.51
|
| CCR1_MOUSE |
Ccr1 |
C-C chemokine receptor type 1 |
1.876e-101 |
0.37
|
| SSR5_MOUSE |
Sstr5 |
Somatostatin receptor type 5 |
2.504e-90 |
0.36
|
| SSR5_HUMAN |
SSTR5 |
Somatostatin receptor type 5 |
1.798e-88 |
0.40
|
| CCR3_HUMAN |
CCR3 |
C-C chemokine receptor type 3 |
1.954e-53 |
0.46
|
| EPHA2_HUMAN |
EPHA2 |
Ephrin type-A receptor 2 |
1.427e-51 |
0.43
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
5.128e-50 |
0.54
|
| HCN1_HUMAN |
HCN1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 |
3.087e-46 |
0.30
|
| UR2R_MACMU |
UTS2R |
Urotensin-2 receptor |
2.321e-45 |
0.36
|
| MTLR_HUMAN |
MLNR |
Motilin receptor |
2.738e-45 |
0.33
|
| DRD1_BOVIN |
DRD1 |
D(1A) dopamine receptor |
2.628e-44 |
0.45
|
| HCN4_HUMAN |
HCN4 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 |
1.764e-43 |
0.30
|
| UR2R_HUMAN |
UTS2R |
Urotensin-2 receptor |
4.256e-42 |
0.38
|
| EPHB4_HUMAN |
EPHB4 |
Ephrin type-B receptor 4 |
1.603e-41 |
0.43
|
| Q03732_HBV |
HBcAg |
Capsid protein |
7.15e-41 |
0.33
|
| Q9JLY8_RAT |
Ccr1 |
C-C motif chemokine receptor 1 |
6.232e-39 |
0.37
|
| EZH2_HUMAN |
EZH2 |
Histone-lysine N-methyltransferase EZH2 |
6.597e-38 |
0.34
|
| HCN2_HUMAN |
HCN2 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 |
1.317e-37 |
0.30
|
| HCN3_HUMAN |
HCN3 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 |
1.317e-37 |
0.30
|
| DRD2_CANLF |
DRD2 |
D(2) dopamine receptor |
9.406e-37 |
0.29
|
| 5HT2A_MOUSE |
Htr2a |
5-hydroxytryptamine receptor 2A |
1.179e-32 |
0.31
|
| CCR1_HUMAN |
CCR1 |
C-C chemokine receptor type 1 |
2.495e-32 |
0.38
|
| DRD2_MOUSE |
Drd2 |
D(2) dopamine receptor |
3.013e-31 |
0.34
|
| MCHR1_HUMAN |
MCHR1 |
Melanin-concentrating hormone receptor 1 |
1.334e-27 |
0.40
|
| SGMR1_MOUSE |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
2.273e-27 |
0.34
|
| DPOL_HHV11 |
|
DNA polymerase catalytic subunit |
2.358e-26 |
0.31
|
| DPOL_VZVD |
|
DNA polymerase catalytic subunit |
2.358e-26 |
0.31
|
| EZH1_HUMAN |
EZH1 |
Histone-lysine N-methyltransferase EZH1 |
4.459e-26 |
0.31
|
| 5HT2B_MOUSE |
Htr2b |
5-hydroxytryptamine receptor 2B |
2.844e-25 |
0.30
|
| Q9X688_CAUVI |
cckA |
Cell cycle histidine kinase CckA |
9.841e-25 |
0.30
|
| FA10_RABIT |
F10 |
Coagulation factor X |
1.592e-24 |
0.31
|
| 5HT1B_MOUSE |
Htr1b |
5-hydroxytryptamine receptor 1B |
2.158e-24 |
0.30
|
| NLRP3_MOUSE |
Nlrp3 |
NACHT, LRR and PYD domains-containing protein 3 |
2.235e-23 |
0.31
|
| DRD4_MOUSE |
Drd4 |
D(4) dopamine receptor |
1.377e-22 |
0.31
|
| G3H407_CRIGR |
|
PROKR2 |
4.029e-21 |
0.34
|
| AEBP2_HUMAN |
AEBP2 |
Zinc finger protein AEBP2 |
1.687e-19 |
0.31
|
| S1PR5_HUMAN |
S1PR5 |
Sphingosine 1-phosphate receptor 5 |
3.527e-19 |
0.34
|
| CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
6.125e-19 |
0.35
|
| CXCR3_RAT |
Cxcr3 |
C-X-C chemokine receptor type 3 |
1.284e-18 |
0.30
|
| G3HIE5_CRIGR |
|
Prokineticin receptor 1 |
3.238e-18 |
0.34
|
| CCR2_HUMAN |
CCR2 |
C-C chemokine receptor type 2 |
4.213e-18 |
0.38
|
| DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
2.212e-17 |
0.55
|
| GRM2_HUMAN |
GRM2 |
Metabotropic glutamate receptor 2 |
2.756e-17 |
0.37
|
| RBBP4_HUMAN |
RBBP4 |
Histone-binding protein RBBP4 |
2.22e-16 |
0.31
|
| SKN1_CAEEL |
skn-1 |
Protein skinhead-1 |
5.551e-16 |
0.36
|
| Q76353_9HIV1 |
|
Integrase |
6.661e-16 |
0.33
|
| HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
9.992e-16 |
0.40
|
| ACKR3_HUMAN |
ACKR3 |
Atypical chemokine receptor 3 |
8.66e-15 |
0.31
|
| 5HT1A_MOUSE |
Htr1a |
5-hydroxytryptamine receptor 1A |
1.266e-14 |
0.30
|
| VACHT_HUMAN |
SLC18A3 |
Vesicular acetylcholine transporter |
3.364e-14 |
0.35
|
| CCR3_MOUSE |
Ccr3 |
Probable C-C chemokine receptor type 3 |
7.361e-14 |
0.32
|
| DRD3_RAT |
Drd3 |
D(3) dopamine receptor |
1.754e-13 |
0.47
|
| Q581W1_TRYB2 |
|
Pteridine reductase, putative |
1.965e-13 |
0.29
|
| EGFR_HUMAN |
EGFR |
Epidermal growth factor receptor |
1.252e-12 |
0.43
|
| MCHR1_MOUSE |
Mchr1 |
Melanin-concentrating hormone receptor 1 |
2.012e-12 |
0.32
|
| SSR1_HUMAN |
SSTR1 |
Somatostatin receptor type 1 |
3.823e-12 |
0.36
|
| CCR3_RAT |
Ccr3 |
C-C chemokine receptor type 3 |
7.19e-12 |
0.32
|
| S6A12_HUMAN |
SLC6A12 |
Sodium- and chloride-dependent betaine transporter |
8.289e-12 |
0.29
|
| CAC1I_HUMAN |
CACNA1I |
Voltage-dependent T-type calcium channel subunit alpha-1I |
1.146e-11 |
0.35
|
| SC6A9_MOUSE |
Slc6a9 |
Sodium- and chloride-dependent glycine transporter 1 |
7.655e-11 |
0.29
|
| Q6Q253_PIG |
5-HT4R |
5-hydroxytryptamine receptor 4 protein |
9.695e-11 |
0.29
|
| 5HT3A_HUMAN |
HTR3A |
5-hydroxytryptamine receptor 3A |
1.159e-10 |
0.45
|
| DCPS_MOUSE |
Dcps |
m7GpppX diphosphatase |
1.878e-10 |
0.33
|
| HSP12_CAEEL |
hsp-16.2 |
Heat shock protein Hsp-16.2 |
2.659e-10 |
0.30
|
| KCNK3_HUMAN |
KCNK3 |
Potassium channel subfamily K member 3 |
2.886e-10 |
0.33
|
| CXCR3_HUMAN |
CXCR3 |
C-X-C chemokine receptor type 3 |
5.19e-10 |
0.33
|
| DRD2_HUMAN |
DRD2 |
D(2) dopamine receptor |
6.161e-10 |
0.53
|
| SUZ12_HUMAN |
SUZ12 |
Polycomb protein SUZ12 |
6.972e-10 |
0.31
|
| PDE5A_CANLF |
PDE5A |
cGMP-specific 3',5'-cyclic phosphodiesterase |
1.622e-09 |
0.37
|
| DRD3_HUMAN |
DRD3 |
D(3) dopamine receptor |
2.701e-09 |
0.53
|
| 5HT2C_MOUSE |
Htr2c |
5-hydroxytryptamine receptor 2C |
2.944e-09 |
0.31
|
| SCNAA_RAT |
Scn10a |
Sodium channel protein type 10 subunit alpha |
6.047e-09 |
0.32
|
| MCHR1_RAT |
Mchr1 |
Melanin-concentrating hormone receptor 1 |
1.122e-08 |
0.35
|
| DPOL_HCMVA |
UL54 |
DNA polymerase catalytic subunit |
2.018e-08 |
0.31
|
| VGFR2_HUMAN |
KDR |
Vascular endothelial growth factor receptor 2 |
2.088e-08 |
0.43
|
| FA10_HUMAN |
F10 |
Coagulation factor X |
6.024e-08 |
0.34
|
| S1PR1_HUMAN |
S1PR1 |
Sphingosine 1-phosphate receptor 1 |
7.828e-08 |
0.33
|
| GNRHR_RAT |
Gnrhr |
Gonadotropin-releasing hormone receptor |
8.007e-08 |
0.34
|
| PDE8A_HUMAN |
PDE8A |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A |
8.63e-08 |
0.29
|
| CXCR3_MOUSE |
Cxcr3 |
C-X-C chemokine receptor type 3 |
6.399e-07 |
0.30
|
| MOGT2_HUMAN |
MOGAT2 |
2-acylglycerol O-acyltransferase 2 |
7.242e-07 |
0.36
|
| KCNQ2_MOUSE |
Kcnq2 |
Potassium voltage-gated channel subfamily KQT member 2 |
7.275e-07 |
0.30
|
| ACES_MOUSE |
Ache |
Acetylcholinesterase |
7.487e-07 |
0.32
|
| CNR2_HUMAN |
CNR2 |
Cannabinoid receptor 2 |
1.129e-06 |
0.38
|
| ADA2A_RAT |
Adra2a |
Alpha-2A adrenergic receptor |
1.729e-06 |
0.45
|
| ACES_HUMAN |
ACHE |
Acetylcholinesterase |
2.84e-06 |
0.44
|
| CHLE_HORSE |
BCHE |
Cholinesterase |
5.297e-06 |
0.38
|
| HRH1_CAVPO |
HRH1 |
Histamine H1 receptor |
5.459e-06 |
0.31
|
| Q7ZJM1_9HIV1 |
pol |
Integrase |
6.279e-06 |
0.31
|